The use of anti-TNFα medications for rheumatologic disease in pregnancy

International Journal of Women's Health

Volumn 2, Issue 1, 2010, Pages 199-209

  Clowse, Megan E B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anti TNF ; Crohn's disease; Medications; Pregnancy; Rheumatoid arthritis; Teratogenesis

Indexed keywords

ADALIMUMAB; CERTOLIZUMAB PEGOL; CORTICOSTEROID; DICLOFENAC; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; FOLIC ACID; GOLIMUMAB; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; LEFLUNOMIDE; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; PREDNISONE; SALAZOSULFAPYRIDINE; SIMPONI; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ANKYLOSING SPONDYLITIS; AORTA ARCH SYNDROME; ARTHRITIS; BLOOD PLACENTA BARRIER; BREAST MILK; CLINICAL TRIAL; CROHN DISEASE; DATA ANALYSIS; DEMYELINATING DISEASE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG INDICATION; DRUG MEGADOSE; DRUG MILK LEVEL; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; ENTERITIS; HUMAN; INFLAMMATION; INJECTION SITE ERYTHEMA; INJECTION SITE PRURITUS; INJECTION SITE REACTION; INJECTION SITE SWELLING; JUVENILE RHEUMATOID ARTHRITIS; LACTATION; LUPUS LIKE SYNDROME; MULTIPLE SCLEROSIS; NONHUMAN; PAIN; PREGNANCY; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS;

EID: 77955531351     PISSN: None     EISSN: 11791411     Source Type: Book Series    
DOI: 10.2147/ijwh.s6029     Document Type: Review

References (58)

1. St Clair EW, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum. 2004;50(11):3432-3443.
2. Singh JA, et al. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2009(4):CD007848.
3. Lee SJ, et al. Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study. J Rheumatol. 2009;36(8):1611-1617.
4. Martinez Lopez JA, Loza E, Carmona L. Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding). Clin Exp Rheumatol. 2009;27(4):678-684.
5. Chambers C, et al. Birth outcomes in pregnant women taking leflunomide. Arthritis Rheum. 2010. In press.
6. Cowchock FS, et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol. 1992;166(5):1318-1323.
7. Ostensen M, von Esebeck M, Villiger PM. Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease. J Rheumatol. 2007;34(6):1266-1269.
8. de Man YA, et al. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59(9):1241-1248.
9. Barrett JH, et al. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum. 1999;42(6):1219-1227.
10. de Man YA. Disease activity and prednisone use influences birth weight in rheumatoid arthritis pregnancies. Arthritis Rheum. 2006; 54(9 Suppl):1319.
11. Chambers CD, Johnson DL, Jones KL. Pregnancy outcome in women exposed to anti-TNF-alpha medications: the OTIS rheumatoid arthritis in pregnancy study. Arthritis Rheum. 2004;52(9 Suppl):Abstract 1224.
12. Dixon WG, et al. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: Results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis. 2010;69(6):1086-1091.
13. Dixon W, Silman A. Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and serious infection? Commentary on the meta-analysis by Bongartz et al. Arthritis Res Ther. 2006;8(5):111.
14. Wiens A, et al. A systematic review and meta-analysis of the efficacy and safety of etanercept for treating rheumatoid arthritis. Scand J Immunol. 2009;70(4):337-344.
15. Saad AA, et al. Risks and benefits of tumor necrosis factor-alpha inhibitors in the management of psoriatic arthritis: systematic review and metaanalysis of randomized controlled trials. J Rheumatol. 2008;35(5):883-890.
16. Bongartz T, et al. Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials. Ann Rheum Dis. 2009;68(7):1177-1183.
17. Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum. 2007;56(9):2886-2895.
18. Ramos-Casals M, et al. Autoimmune diseases induced by biological agents A double-edged sword? Autoimmun Rev. 2010;9(3): 188-193.
19. Kane SV, Acquah LA. Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol. 2009;104(1):228-233.
20. Stephens S, Nesbitt A, Foulkes R. Placental transfer of the anti-TNF antibody TN3 in rats: comparison of immunoglobulin G1 and pegylated FAB versions [abstract]. Gut. 2006;55(Suppl 7):A8.
21. Vasiliauskas EA, et al. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol. 2006;4(10):1255-1258.
22. Cush JJ. Biological drug use: US perspectives on indications and monitoring. Ann Rheum Dis. 2005;64 Suppl 4:iv18-23.
23. Katz JA, et al. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol. 2004;99(12):2385-2392.
24. Srinivasan R. Infliximab treatment and pregnancy outcome in active Crohn's disease. Am J Gastroenterol. 2001;96(7):2274-2275.
25. Tursi A. Effect of intentional infliximab use throughout pregnancy in inducing and maintaining remission in Crohn's disease. Dig Liver Dis. 2006;38(6):439-440.
26. Angelucci E, et al. Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception. Inflamm Bowel Dis. 2008;14(3):435-436.
27. Burt MJ, Frizelle FA, Barbezat GO. Pregnancy and exposure to infliximab (anti-tumor necrosis factor-alpha monoclonal antibody). J Gastroenterol Hepatol. 2003;18(4):465-466.
28. Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J Rheumatol. 2003;30(2):241-246.
29. Kinder AJ, et al. Pregnancy in a rheumatoid arthritis patient on infliximab and methotrexate. Rheumatology (Oxford). 2004;43(9):1195-1196.
30. Johnson DL, et al. Pregnancy outcomes in women exposed to etanercept: The OTIS Autoimme Diseases in Pregnancy Project. Arthritis Rheum. 2008;58(9 Suppl):Abstract 1387.
31. Murashima A, et al. Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum. Ann Rheum Dis. 2009; 68(11):1793-1794.
32. Johnson, DL, et al. Pregnancy outcomes for women exposed to adalimumab: OTIS Autoimmune Diseases in Pregnancy Project. Arthritis Rheum. 2008;58(9 Suppl):Abstract 1388.
33. Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut. 2005;54(6):890.
34. Mishkin DS, et al. Successful use of adalimumab (Humira) for Crohn's disease in pregnancy. Inflamm Bowel Dis. 2006;12(8):827-828.
35. Coburn LA, Wise PE, Schwartz DA, The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy. Dig Dis Sci. 2006;51(11):2045-2047.
36. Kraemer B, et al. A successful pregnancy in a patient with Takayasu's arteritis. Hypertens Pregnancy. 2008;27(3):247-252.
37. Oussalah A, Bigard MA, Peyrin-Biroulet L. Letter: Certolizumab use in pregnancy. Gut. 2009;58:608.
38. Mahadevan U, Abreu M. Certolizumab use in pregnancy: low levels detected in cord blood. Gastroenterology. 2009;136(3 Suppl 1):A146.
39. Martin PL, Oneda S, Treacy G. Effects of an anti-TNF-alpha monoclonal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system. Am J Reprod Immunol. 2007;58(2):138-149.
40. Carter JD, Valeriano J, Vasey FB. Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship. J Rheumatol. 2006;33(5):1014-1017.
41. Carter JD, et al. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol. 2009;36(3):635-641.
42. Reardon W, Zhou XP, Eng C. A novel germLine mutation of the PTEN gene in a patient with macrocephaly, ventricular dilatation, and features of VATER association. J Med Genet. 2001;38(12):820-823.
43. Koren G, Inoue M. Do tumor necrosis factor inhibitors cause malformations in humans? J Rheumatol. 2009;36(3):465-466.
44. Winger EE, Reed JL. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol. 2008;60:8-16.
45. Winger EE, et al. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol. 2009;61(2):113-120.
46. Winger EE, et al. Birth defect rates in women using adalimumab (Humira) and intravenous immunoglobulin to treat immunologic-based infertility in IVF. J Reprod Immunol. 2009;81:169-170.
47. Mahadevan U, et al. Infliximab and semen quality in men with inflammatory bowel disease. Inflamm Bowel Dis. 2005;11(4):395-399.
48. Said TM, et al. Infliximab may reverse the toxic effects induced by tumor necrosis factor alpha in human spermatozoa: an in vitro model. Fertil Steril. 2005;83(6):1665-1673.
49. Paschou S, et al. Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab. J Rheumatol. 2009;36(2):351-354.
50. Lachter J, et al. Resolution of male infertility following anti-tumor necrosis factor (infliximab): a case report. The Internet Journal of Gastroenterology. 2004;3(1).
51. Rezvani A, Ozaras J. Infertility improved by etanercept in ankylosing spondylitis. Indian Journal of Pharmacology. 2008;40(6):276-277.
52. Kane S, et al. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery. J Clin Gastroenterol. 2009;43:613-616.
53. Peltier M, et al. Infliximab levels in breast milk of a nursing Crohn's patient [poster]. American College of Gastroenterology 2001: Poster #P258.
54. Stengel JZ, Arnold HL. Is infliximab safe to use while breastfeeding? World J Gastroenterol. 2008;14:3085-3087.
55. Ostensen M, Eigenmann GO. Etanercept in breast milk. J Rheumatol. 2004;31(5):1017-1018.
56. Forger F, et al. Infliximab in breast milk. Lupus. 2004;13:753.
57. Hale TW. Medications and Mother's Milk. 12th edition. Amarillo, TX: Hale Publishing; 2006.
58. Caprilli R, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut. 2006;55 Suppl 1:i36-58.